Volume 16, issue 1, December 2018
35 articles in this issue
-
-
Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study
Authors (first, second and last of 20)
-
-
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study
Authors (first, second and last of 10)
-
Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study
Authors (first, second and last of 13)
-
Combination of acquired von Willebrand syndrome (AVWS) and Glanzmann thrombasthenia in monoclonal gammopathy of uncertain significance (MGUS), a case report
Authors (first, second and last of 5)
-
Clinical presentation and therapeutic management of venous thrombosis in young children: a retrospective analysis
Authors (first, second and last of 25)
-
Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study
Authors (first, second and last of 10)
-
Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis
Authors (first, second and last of 6)
-
Antithrombotic therapy with rivaroxaban in five patients with paroxysmal nocturnal haemoglobinuria and thrombotic events
Authors (first, second and last of 5)
-
-
Circulating activated protein C levels are not increased in septic patients treated with recombinant human soluble thrombomodulin
Authors (first, second and last of 13)
-
-
-
COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study
Authors (first, second and last of 7)
-
-
-
-
Decreased antithrombin activity in the early phase of trauma is strongly associated with extravascular leakage, but not with antithrombin consumption: a prospective observational study
Authors (first, second and last of 10)
-
-
Correction to: Prognostic assessment for patients with cancer and incidental pulmonary embolism
Authors (first, second and last of 9)
-
Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy
Authors (first, second and last of 7)
-
-
Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis
Authors (first, second and last of 10)
-
Could sodium imbalances predispose to postoperative venous thromboembolism? An analysis of the NSQIP database
Authors (first, second and last of 4)
-
-
-
Prognostic assessment for patients with cancer and incidental pulmonary embolism
Authors (first, second and last of 9)
-
NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands
Authors (first, second and last of 6)
-
Combined life-threatening thromboses and hemorrhages in a patient with afibrinogenemia and antithrombin deficiency
Authors (first, second and last of 7)
-
Differential impact of diabetes mellitus on antiplatelet effects of prasugrel and clopidogrel
Authors
-
The diagnosis and treatment of venous thromboembolism in Asian patients
Authors (first, second and last of 6)
-
Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation
Authors (first, second and last of 10)
-
Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look!
Authors (first, second and last of 14)
-
Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
Authors (first, second and last of 6)
